MétaCan
Menu
Back to cohort
Record W2154257259 · doi:10.1093/aje/kwr141

Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated With Antiretroviral Drugs in North America

2011· article· en· W2154257259 on OpenAlexfundno aff
Alison G. Abraham, B. Lau, Steven G. Deeks, Richard D. Moore, Jing Zhang, J. Eron, Richard A. Harrigan, M. John Gill, M. Kitahata, Marina B. Klein, S. Napravnik, A. Rachlis, Benigno Rodríguez, Sean B. Rourke, Constance A. Benson, R. Bosch, Ann C. Collier, Kelly A. Gebo, James J. Goedert, Robert S. Hogg, Michael A. Horberg, Lisa P. Jacobson, A. Justice, Gregory D. Kirk, Jack A. Martin, Rosemary G. McKaig, Michael J. Silverberg, T. Sterling, J.E Thorne, James H. Willig, Stephen J. Gange

Bibliographic record

VenueAmerican Journal of Epidemiology · 2011
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsnot available
FundersNational Institute of Allergy and Infectious DiseasesNational Eye InstituteNational Center for Research ResourcesNational Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismCanadian Institutes of Health ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Drug AbuseU.S. Public Health ServiceNational Cancer InstituteNational Institutes of Health
KeywordsHuman immunodeficiency virus (HIV)VirologyDrug resistanceMedicineDrugAntiretroviral drugEstimationHIV drug resistanceEnvironmental healthAntiretroviral therapyBiologyPharmacologyViral loadMicrobiology

Abstract

fetched live from OpenAlex

Determination of the prevalence of accumulated antiretroviral drug resistance among persons infected with human immunodeficiency virus (HIV) is complicated by the lack of routine measurement in clinical care. By using data from 8 clinic-based cohorts from the North American AIDS Cohort Collaboration on Research and Design, drug-resistance mutations from those with genotype tests were determined and scored using the Genotypic Resistance Interpretation Algorithm developed at Stanford University. For each year from 2000 through 2005, the prevalence was calculated using data from the tested subset, assumptions that incorporated clinical knowledge, and multiple imputation methods to yield a complete data set. A total of 9,289 patients contributed data to the analysis; 3,959 had at least 1 viral load above 1,000 copies/mL, of whom 2,962 (75%) had undergone at least 1 genotype test. Using these methods, the authors estimated that the prevalence of accumulated resistance to 2 or more antiretroviral drug classes had increased from 14% in 2000 to 17% in 2005 (P < 0.001). In contrast, the prevalence of resistance in the tested subset declined from 57% to 36% for 2 or more classes. The authors' use of clinical knowledge and multiple imputation methods revealed trends in HIV drug resistance among patients in care that were markedly different from those observed using only data from patients who had undergone genotype tests.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.032
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.992
Threshold uncertainty score0.044

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.032
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.312
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designObservational
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of EpidemiologySame topicHIV/AIDS drug development and treatmentFrench-language works237,207